TB-HIV Innovations & Clinical Research Foundation Corp

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis	Active, not recruiting	Phase 2	2026-07-08		NCT03828201

Clinical trials